Practical considerations for introducing biosimilars

Bookmark and Share
Published: 25 Sep 2019
Views: 896
Simon Cheesman - University College Hospital, London, UK

Simon Cheesman speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the practical considerations for introducing biosimilars.

He details some of the different factors, besides price and time to market, that would help you choose between different biosimilar products.

He explains that these considerations do differ globally but that they tend to be weighted differently in different countries.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.